# Impact of OCT1 on Metformin Tolerance

> **NCT02586636** · PHASE4 · COMPLETED · sponsor: **NHS Tayside** · enrollment: 61 (actual)

## Conditions studied

- Tolerance

## Interventions

- **DRUG:** Metformin
- **DRUG:** Omeprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02586636
- **Lead sponsor:** NHS Tayside
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2018-04-09
- **Final completion:** 2018-04-09
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2018-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02586636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02586636, "Impact of OCT1 on Metformin Tolerance". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02586636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*